This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
2MF Holick (2003) Vitamin D: a millennium perspective. J Cell Biochem 88, 296–307.
4GM Bull & J Morton (1975) Seasonal and short-term relationships of temperature with deaths from myocardial and cerebral infarction. Age Ageing 4, 19–31.
5R Scragg (1981) Seasonality of cardiovascular disease mortality and the possible protective effect of ultraviolet radiation. Int J Epidemiol 10, 337–341.
6DS Grimes , E Hindle & T Dyer (1996) Sunlight, cholesterol and coronary heart disease. QJM 89, 579–589.
7SG Rostand (1997) Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension 30, 150–156.
9B Caballero (2007) The global epidemic of obesity: an overview. Epidemiol Rev 29, 1–5.
10GA Bray & T Bellanger (2006) Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine 29, 109–117.
11C Sarti & J Gallagher (2006) The metabolic syndrome: prevalence, CHD risk, and treatment. J Diabetes Complications 20, 121–132.
12SJ Parikh , M Edelman , GI Uwaifo , et al. (2004) The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 89, 1196–1199.
13PW Wilson , WB Kannel , H Silbershatz , et al. (1999) Clustering of metabolic factors and coronary heart disease. Arch Intern Med 159, 1104–1109.
14R Krause , M Buhring , W Hopfenmuller , et al. (1998) Ultraviolet B and blood pressure. Lancet 352, 709–710.
15J Merke , W Hofmann , D Goldschmidt , et al. (1987) Demonstration of 1,25(OH)2 vitamin D3 receptors and actions in vascular smooth muscle cells in vitro. Calcif Tissue Int 41, 112–114.
16J Merke , P Milde , S Lewicka , et al. (1989) Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3: studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest 83, 1903–1915.
17R Scragg , M Sowers & C Bell (2007) Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens 20, 713–719.
18R Jorde , Y Figenschau , N Emaus , et al. (2010) Serum 25-hydroxyvitamin D levels are strongly related to systolic blood pressure but do not predict future hypertension. Hypertension 55, 792–798.
19MF Holick (2006) High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81, 353–373.
20YC Li , J Kong , M Wei , et al. (2002) 1,25-Dihydroxyvitamin D (3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110, 229–238.
21SG Rostand & TB Drueke (1999) Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int 56, 383–392.
22PN Sambrook , JS Chen , LM March , et al. (2004) Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxy vitamin D status, bone mass and renal function in the frail and very old: a cohort study. J Clin Endocrinol Metab 89, 5477–5481.
23S Hashemipour , B Larijani , H Adibi , et al. (2004) Vitamin D deficiency and causative factors in the population of Tehran. BMC Public Health 4, 38–44.
27CL Craig , AL Marshall , M Sjostrom , et al. (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35, 1381–1395.
28FH Esfahani , G Asghari , P Mirmiran , et al. (2010) Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the Tehran Lipid and Glucose Study. J Epidemiol 20, 150–158.
32DX Tishkoff , KA Nibbelink , KH Holmberg , et al. (2008) Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility. Endocrinology 149, 558–564.
33E Giovannucci , Y Liu , BW Hollis , et al. (2008) 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 168, 1174–1180.
34H Dobnig , S Pilz , H Scharnagl , et al. (2008) Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 168, 1340–1349.
35TJ Wang , MJ Pencina , SL Booth , et al. (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117, 503–511.
36MB Snijder , P Lips , JC Seidell , et al. (2007) Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J Intern Med 261, 558–565.
37A Zittermann , S Frisch , HK Berthold , et al. (2009) Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 89, 1321–1327.
39M Pfeifer , B Begerow , HW Minne , et al. (2001) Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 86, 1633–1637.
40KD Schluter & H Piper (1998) Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide. Cardiovasc Res 37, 34–41.
42D Somjen , Y Weisman , F Kohen , et al. (2005) 25-Hydroxyvitamin D3-1α-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 111, 1666–1671.
44V Perkovic , TD Hewitson , KJ Kelynack , et al. (2003) Parathyroid hormone has a prosclerotic effect on vascular smooth muscle cells. Kidney Blood Press Res 26, 27–33.
45P Andersson , E Rydberg & R Willenheimer (2004) Primary hyperparathyroidism and heart disease – a review. Eur Heart J 25, 1776–1787.
46N Garcia de la Torre , JA Wass & HE Turner (2003) Parathyroid adenomas and cardiovascular risk. Endocr Relat Cancer 10, 309–322.
47JL Martin-Ventura , M Ortego , P Esbrit , et al. (2003) Possible role of parathyroid hormone-related protein as a proinflammatory cytokine in atherosclerosis. Stroke 34, 1783–1789.
48RN Foley , PS Parfrey & MJ Sarnaak (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32, 5 Suppl. 3, S112–S119.
49P Khajehdehi & S Taheri (2003) Effect of oral calcitriol pulse therapy on the lipid, calcium, and glucose homeostasis of hemodialysis patients: its safety in a combination with oral calcium carbonate. J Ren Nutr 13, 78–83.
53MJ Barger-Lux , RP Heaney , SJ Lanspa , et al. (1995) An investigation of sources of variation in calcium absorption efficiency. J Clin Endocrinol Metab 80, 406–411.
55IR Reid (2004) Effects of calcium supplementation on circulating lipids: potential pharmacoeconomic implications. Drugs Aging 21, 7–17.
58S Malik (2003) Transcriptional regulation of the apolipoprotein AI gene. Front Biosci 8, d360–d368.
59J Auwerx , R Bouillon & H Kesteloot (1992) Relation between 25-hydroxyvitamin D3, apolipoprotein A-1 and high density lipoprotein cholesterol. Aterioscler Thromb 12, 671–674.
60K Wehmeier , A Beers , MJ Haas , et al. (2005) Inhibition of apolipoprotein AI gene expression by 1,25-dihydroxyvitamin D3. Biochim Biophys Acta 1737, 16–26.